Drug therapies for attentional disorders alter the signal-to-noise ratio in the superior colliculus

Neuroscience

Volumn 164, Issue 3, 2009, Pages 1369-1376

  Dommett, E J ^a   Overton, P G ^b   Greenfield, S A ^c  

^a OPEN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

attention deficit hyperactivity disorder; d amphetamine.; methylphenidate; superior colliculus

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE; SEROTONIN;

ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; DRUG MECHANISM; IN VITRO STUDY; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; SUPERIOR COLLICULUS; SYNAPTIC TRANSMISSION; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; ARTIFACTS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; MALE; METHYLPHENIDATE; ORGAN CULTURE TECHNIQUES; PRESYNAPTIC TERMINALS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; SEROTONIN; SIGNAL PROCESSING, COMPUTER-ASSISTED; SUPERIOR COLLICULI; SYNAPTIC TRANSMISSION;

EID: 70350542588     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.09.007     Document Type: Article

References (56)

1. Agmo A., Belzung C., and Rodriguez C. A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission. J Neural Transm 104 (1997) 11-29
2. Andersen S.L., Napierata L., Brenhouse H.C., and Sonntag K.C. Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors. Eur J Neurosci 27 (2008) 2962-2972
3. Azzaro A.J., Ziance R.J., and Rutledge C.O. The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue. J Pharmacol Exp Ther 189 (1974) 110-118
4. Barrickman L., Noyes R., Kuperman S., Schumacher E., and Verda M. Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 30 (1991) 762-767
5. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 57 (2005) 1215-1220
6. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
7. Binns K.E., and Salt T.E. Different roles for GABAA and GABAB receptors in visual processing in the rat superior colliculus. J Physiol 504 Pt 3 (1997) 629-639
8. Bizarro L., Patel S., Murtagh C., and Stolerman I.P. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol 15 (2004) 195-206
9. Brown C.S., and Cooke S.C. Attention deficit hyperactivity disorder. Clinical features and treatment options. CNS Drugs 1 (1994) 95-106
10. Chevalier G., and Deniau J.M. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci 13 (1990) 277-280
11. Douglas V. Attention and cognitive problems. In: Rutter M. (Ed). Developmental neuropsychiatry (1983), Guildford Press, New York 280-329
12. Easton N., Steward C., Marshall F., Fone K., and Marsden C. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology 52 (2007) 405-414
13. Elliott R., Sahakian B.J., Matthews K., Bannerjea A., Rimmer J., and Robbins T.W. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl) 131 (1997) 196-206
14. Faraone S.V., Wigal S.B., and Hodgkins P. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with ADHD. J Atten Disord 11 (2007) 74-82
15. Funke K., and Eysel U.T. Modulatory effects of acetylcholine, serotonin and noradrenaline on the activity of cat perigeniculate neurons. Exp Brain Res 95 (1993) 409-420
16. Gal J., Hodshon B.J., Pintauro C., Flamm B.L., and Cho A.K. Pharmaco-kinetics of methylphenidate in the rat using single-ion monitoring GLC-mass spectrometry. J Pharm Sci 66 (1977) 866-869
17. Gaymard B., Francois C., Ploner C.J., Condy C., and Rivaud-Pechoux S. A direct prefrontotectal tract against distractibility in the human brain. Ann Neurol 53 (2003) 542-545
18. Gibson A.P., Bettinger T.L., Patel N.C., and Crismon M.L. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Ann Pharmacother 40 (2006) 1134-1142
19. Goldberg M.E., and Wurtz R.H. Activity of superior colliculus in behaving monkey. II. Effect of attention on neuronal responses. J Neurophysiol 35 (1972) 560-574
20. Goodale M.A., Foreman N.P., and Milner A.D. Visual orientation in the rat: a dissociation of deficits following cortical and collicular lesions. Exp Brain Res 31 (1978) 445-457
21. Gowan J.D., Coizet V., Devonshire I.M., and Overton P.G. D-amphetamine depresses visual responses in the rat superior colliculus: a possible mechanism for amphetamine-induced decreases in distractibility. J Neural Transm 115 (2008) 377-387
22. Grasse K.L., Douglas R.M., and Mendelson J.R. Alterations in visual receptive fields in the superior colliculus induced by amphetamine. Exp Brain Res 92 (1993) 453-466
23. Greenhill L.L., Perel J.M., Rudolph G., Feldman B., Curran S., Puig-Antich J., and Gardner R. Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHD. Int J Neuropsychopharmacol 4 (2001) 207-215
24. Gurney K., Prescott T.J., and Redgrave P. A computational model of action selection in the basal ganglia. I. A new functional anatomy. Biol Cybern 84 (2001) 401-410
25. Halliday R., Gregory K., Naylor H., Callaway E., and Yano L. Beyond drug effects and dependent variables: the use of the Poisson-Erlang model to assess the effects of D-amphetamine on information processing. Acta Psychol (Amst) 73 (1990) 35-54
26. Holmes J.C., and Rutledge C.O. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain. Biochem Pharmacol 25 (1976) 447-451
27. Hoshino Y., Ohno Y., Yamamoto T., Kaneko M., and Kumashiro H. Plasma free tryptophan concentration in children with attention deficit disorder. Folia Psychiatr Neurol Jpn 39 (1985) 531-535
28. Isa T., Endo T., and Saito Y. The visuo-motor pathway in the local circuit of the rat superior colliculus. J Neurosci 18 (1998) 8496-8504
29. Kiyatkin E.A., and Rebec G.V. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J Neurophysiol 75 (1996) 142-153
30. Kuczenski R., and Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9 (1989) 2051-2065
31. Lee P.H., Helms M.C., Augustine G.J., and Hall W.C. Role of intrinsic synaptic circuitry in collicular sensorimotor integration. Proc Natl Acad Sci U S A 94 (1997) 13299-13304
32. Liang X., Arvanov V.L., and Wang R.Y. Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227A and 5-HT: intracellular studies. Synapse 29 (1998) 257-268
33. Mackworth J.F. The effect of amphetamine on the detectability of signals in a vigilance task. Can J Psychol 19 (1965) 104-110
34. Marcoli M., Maura G., Tortarolo M., and Raiteri M. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in rat cerebellum: involvement of 5-hydroxytryptamine2C receptors. J Neurochem 69 (1997) 427-430
35. McGough J.J., Biederman J., Greenhill L.L., McCracken J.T., Spencer T.J., Posner K., Wigal S., Gornbein J., Tulloch S., and Swanson J.M. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. J Am Acad Child Adolesc Psychiatry 42 (2003) 684-691
36. McHaffie J.G., Stanford T.R., Stein B.E., Coizet V., and Redgrave P. Subcortical loops through the basal ganglia. Trends Neurosci 28 (2005) 401-407
37. McIlwain J.T., and Buser P. Receptive fields of single cells in the cat's superior colliculus. Exp Brain Res 5 (1968) 314-325
38. Milner A.D., Foreman N.P., and Goodale M.A. Go-left go-right discrimination performance and distractibility following lesions of prefrontal cortex or superior colliculus in stumptail macaques. Neuropsychologia 16 (1978) 381-390
39. Mooney R.D., Huang X., Shi M.Y., Bennett-Clarke C.A., and Rhoades R.W. Serotonin modulates retinotectal and corticotectal convergence in the superior colliculus. Prog Brain Res 112 (1996) 57-69
40. Overton P., Dean P., and Redgrave P. Detection of visual stimuli in far periphery by rats: possible role of superior colliculus. Exp Brain Res 59 (1985) 559-569
41. Overton P.G. Collicular dysfunction in attention deficit hyperactivity disorder. Med Hypotheses 70 (2008) 1121-1127
42. Parent A., Descarries L., and Beaudet A. Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine. Neuroscience 6 (1981) 115-138
43. Platt B., and Withington D.J. Paired-pulse depression in the superficial layers of the guinea-pig superior colliculus. Brain Res 777 (1997) 131-139
44. Redgrave P., Prescott T.J., and Gurney K. The basal ganglia: a vertebrate solution to the selection problem?. Neuroscience 89 (1999) 1009-1023
45. Ricaurte G.A., Mechan A.O., Yuan J., Hatzidimitriou G., Xie T., Mayne A.H., and McCann U.D. Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates. J Pharmacol Exp Ther 315 (2005) 91-98
46. Rice M.E., and Cragg S.J. Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7 (2004) 583-584
47. Riffee W.H., Ludden T.M., Wilcox R.E., and Gerald M.C. Brain and plasma concentrations of amphetamine isomers in mice. J Pharmacol Exp Ther 206 (1978) 586-594
48. Rolls E.T., Thorpe S.J., Boytim M., Szabo I., and Perrett D.I. Responses of striatal neurons in the behaving monkey3. Effects of iontophoretically applied dopamine on normal responsiveness. Neuroscience 12 (1984) 1201-1212
49. Segu L., Abdelkefi J., Dusticier G., and Lanoir J. High-affinity serotonin binding sites: autoradiographic evidence for their location on retinal afferents in the rat superior colliculus. Brain Res 384 (1986) 205-217
50. Sparks D.L. Conceptual issues related to the role of the superior colliculus in the control of gaze. Curr Opin Neurobiol 9 (1999) 698-707
51. Spencer T., Biederman J., Wilens T., Faraone S., Prince J., Gerard K., Doyle R., Parekh A., Kagan J., and Bearman S.K. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58 (2001) 775-782
52. Spencer T.J., Biederman J., Wilens T.E., and Faraone S.V. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 63 Suppl 12 (2002) 3-9
53. Thorley G. Hyperkinetic syndrome of childhood: clinical characteristics. Br J Psychiatry 144 (1984) 16-24
54. Waterhouse B.D., Moises H.C., and Woodward D.J. Interaction of serotonin with somatosensory cortical neuronal responses to afferent synaptic inputs and putative neurotransmitters. Brain Res Bull 17 (1986) 507-518
55. Weller M.E., Rose S., Jenner P., and Marsden C.D. In vitro characterisation of dopamine receptors in the superior colliculus of the rat. Neuropharmacology 26 (1987) 347-354
56. Zucker R.S. Short-term synaptic plasticity. Annu Rev Neurosci 12 (1989) 13-31